Viatris Inc. Common Stock (VTRS) is a publicly traded Healthcare sector company. As of November 17, 2026, VTRS trades at $20.65 with a market cap of $23.87B and a P/E ratio of -49.18. VTRS moved -0.46% today. Year to date, VTRS is +66.34%; over the trailing twelve months it is +93.34%. Its 52-week range spans $6.85 to $21.20. Analyst consensus is buy with an average price target of $21.00. Rallies surfaces VTRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for VTRS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $20.65 |
| Market Cap | $23.87B |
| P/E Ratio | -49.18 |
| EPS | $-0.36 |
| Dividend Yield | 0.12% |
| 52-Week High | $21.20 |
| 52-Week Low | $6.85 |
| Volume | 35 |
| Avg Volume | 0 |
| Revenue (TTM) | $14.74B |
| Net Income | $-410.70M |
| Gross Margin | 34.83% |
9 analysts cover VTRS: 0 strong buy, 5 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $21.00.